Research Feed
Broadwood Activist Play: STAAR Surgical Inflecting to Profitability, Options Cheap Into Feb 10 Earnings
Broadwood Partners forced CEO change at STAAR Surgical after accumulating $70M+ stake. Stock down 20% in a month (RSI 16.9), options IV at 5th percentile. Company just turned profitable: Q3 $0.47 EPS beat vs $0.30 est. Earnings Feb 10 — 8 days away. Item 5.02: Warren Foust (President/COO) and Debora